By Kate O’Rourke
In patients with stage I hepatocellular carcinoma of 5 cm or less, overall survival was superior with resection compared with radiofrequency ablation, according to a matched-cohort study presented at the 2018 Society of Surgical Oncology Annual Cancer Symposium (abstract 46). Although the researchers concluded that resection is underused, others say the issue is more nuanced.
Presenting the data, lead author Andrew Newton, MD, a PGY-5 general surgery resident at the